DFDA

H1 and H2 Antihistamines (e.g., Fexofenadine, Famotidine)

Treatment for Long Covid

Typical Dosage: Standard OTC doses (e.g., Fexofenadine 180mg daily, Famotidine 20-40mg twice daily)

Effectiveness
50%
Safety Score
80%
Clinical Trials
8
Participants
350

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
Standard OTC doses (e.g., Fexofenadine 180mg daily, Famotidine 20-40mg twice daily)
Time to Effect
Days to 2 weeks
Treatment Duration
Months to years, as needed
Evidence Quality
VERY-LOW
Confidence Score
40%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$120
Monitoring:$50
Side Effect Mgmt:$0
Total Annual:$170
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$485.71
H1 and H2 Antihistamines (e.g., Fexofenadine, Famotidine) Outcomes

for Long Covid

Efficacy Outcomes
Overall Effectiveness
+50%
Response Rate
+35%
Common Side Effects
Drowsiness (H1)
+15%
Dry mouth
+7%
Headache
+6%

Sources:

medscape.co.uk
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov